Abstract

Chung H. Kok, Anna L. Brown, Michelle Perugini, Diana G. Iarossi, Ian D. Lewis, Richard J. D’Andrea

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Impact of Race/Ethnicity on Pediatric Core Binding Factor AML Outcomes and Response to Gemtuzumab Ozogamicin
Rachel E Rau ... Shannon E Conneely
Blood | VOL. 136
Rachel E Rau, et. al.Rachel E Rau ... Shannon E Conneely
05 Nov 2020
Association of c-Kit mutations with higher likelihood of recurrence of t(8;21) AML
-
Cancer Biology & Therapy | VOL. 5
--
01 Jul 2006
High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia
Huiyu Li ... Yaokun Ma
Journal of Translational Medicine | VOL. 17
Huiyu Li, et. al.Huiyu Li ... Yaokun Ma
06 Jun 2019
Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements
Geneviève Boucher ... Sébastien Lemieux
Blood | VOL. 126
Geneviève Boucher, et. al.Geneviève Boucher ... Sébastien Lemieux
03 Dec 2015
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
Assessment of fatigue in adult patients with sickle cell disease: Useof the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaire.
Geoffrey Cheminet ... Jean‐Benoît Arlet
British journal of haematology | VOL. -
Geoffrey Cheminet, et. al.Geoffrey Cheminet ... Jean‐Benoît Arlet
27 May 2024
View more papers